Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year?
Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Apyx Medical (APYX) have performed compared to their sector so far this year.
Zacks·18h ago
More News
Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
Renuvion wins 2026 NewBeauty Award for 'Best Minimally Invasive Skin Tightener' Renuvion wins 2026 NewBeauty Award for 'Best Minimally Invasive Skin Tightener' PR Newswire CLEARWATER, Fla., April 1...
PR Newswire·2d ago
Tilray Brands' Q3 Earnings on the Horizon: What's in The Offing?
TLRY heads into Q3 FY26 earnings with projected revenues up 10.9% and narrower losses, but margin pressure in cannabis and beverages clouds the outlook.
Zacks·3d ago
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?
Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Apyx Medical (APYX) have performed compared to their sector so far this year.
Zacks·17d ago
Apyx Medical Corporation (NASDAQ:APYX) Short Interest Up 22.3% in February
Apyx Medical Corporation (NASDAQ:APYX - Get Free Report) was the recipient of a significant increase in short interest in February. As of February 27th, there was short interest totaling 173,573...
MarketBeat·18d ago
Apyx Medical Calls AYON a Game Changer at Citizens Conference, Targets Profitability in 2025
Apyx Medical (NASDAQ:APYX) executives used a conference discussion at the Citizens Life Sciences Conference to describe what CEO Charlie Goodwin called a fundamentally different company following the...
MarketBeat·22d ago
Apyx Medical (NASDAQ:APYX) Stock Price Expected to Rise, Craig Hallum Analyst Says
Craig Hallum upped their price target on Apyx Medical from $5.00 to $6.00 and gave the company a "buy" rating in a report on Wednesday...
MarketBeat·23d ago
Apyx Medical Corporation (NASDAQ:APYX) Given Average Rating of "Moderate Buy" by Brokerages
Apyx Medical Corporation (NASDAQ:APYX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five brokerages that are currently covering the firm, MarketBeat Ratings reports. One...
MarketBeat·23d ago
Apyx Medical (NASDAQ:APYX) Upgraded to Buy at BTIG Research
BTIG Research raised shares of Apyx Medical from a "neutral" rating to a "buy" rating and set a $6.00 price target on the stock in a research note on Wednesday...
MarketBeat·23d ago
This JM Smucker Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Wall Street analysts upgraded Uniqure NV, Apyx Medical Inc, J M Smucker Co, and VTEX with raised price targets. See analyst ratings page.read more...